|
V.V. Fomin
Opening remarks
|
|
|
E.A.Katunina
VASCULAR COGNITIVE IMPAIRMENTS AND POTENTIALS FOR THEIR CORRECTION
|
12-16 |
|
N.A. Shostak
OSTEOARTHROSIS -2012 - NEW TRENDS IN TREATMENT
|
17-22 |
|
V.M. Studenikin, S.S. Tursunkhuzhayeva, L.M. Kuzenkova, L.A. Pak, V.I. Shelkovsky, Yu.S. Akoyev
MAGNESIUM-CONTAINING DRUGS IN THE CORRECTION OF HYPEREXCITABILITY IN CHILDREN
|
23-26 |
|
N.A. Shostak, N.G. Pravdyuk, A.A. Klimenko
DISEASE OF PERIARTICULAR TISSUES OF WRIST AND HAND - DIFFERENTIAL DIAGNOSIS, AND APPROACHES TO THE TREATMENT
|
27-30 |
|
M.G. Poluektov, S.L. Tsenteradze
POTENTIALS FOR THE USE OF MELATONIN IN ISCHEMIC STROKE
|
31-35 |
|
Yu.E. Asimova
STRATEGY AND APPROACH TO THE TREATMENT OF HEADACHE
|
36-40 |
|
E.G. Zotkin
CHRONIC PERSISTENT PAIN ASSOCIATED WITH RHEUMATIC DISEASES IN OLDER PATIENTS
|
41-46 |
|
M. Yu.Maximova, N.A. Ryazantsev, E.N. Anisimova
APPROACHES TO PROVIDING DENTAL CARE FOR PATIENTS WITH CEREBROVASCULAR DISEASE
|
47-51 |
|
N.V. Samoylova, O.I. Zagorulko, A.V. Gnezdilov, L.A. Medvedev
CLINICAL EXPERIENCE OF USE OF NISE IN COMPLEX TREATMENT OF PATIENTS WITH PAIN IN THE KNEE JOINT
|
52-57 |
|
L.I. Alekseeva, S.G. Anikin, E.M. Zaitseva, N.G. Kashevarova, T.A. Korotkova, E.P. Sharapova, N.V. Chichasova, G.R. Imametdinova, N.V. Badokin, S.A. Kolova
EVALUATION OF EFFICACY, TOLERABILITY AND SAFETY OF THE DRUG CHONDROGARD IN PATIENTS WITH OSTEOARTHROSIS
|
58-62 |
|
M.Yu. Zubareva, T.A. Rozhkova, V.A. Amelyushkina; A.V. Susekov, V.V. Kukharchuk
EFFICACY, SAFETY AND TOLERABILITY OF ROSUVASTATIN AT A DOSE OF 40 MG DAILY IN VERY HIGH CARDIOVASCULAR RISK PATIENTS WITH PRIMARY HYPERCHOLESTEROLEMIA. RESULTS OF 24-WEEK "40 × 40"STUDY
|
63-68 |
|
V.A. Krasnogolovy; S.A. Rabinovich, V.F. Prikuls, A.I. Evdokimov
EVALUATION OF SENSITIVITY THRESHOLDS OF SKIN AND THE DEGREE OF HYDRATION OF THE PERIODONTAL TISSUES IN INFERIOR ALVEOLAR NERVE NEUROPATHY
|
69-72 |
|
S.G. Anikin, L.I. Alekseyeva
THE USE OF XEFOCAM (LORNOXICAM) IN PATIENTS WITH OSTEOARTHROSIS
|
73-77 |
|
O.B. Ershova, A.V. Nazarova
BISPHOSPHONATES - DURATION OF USE IN OSTEOPOROSIS, REASONABILITY AND SAFETY
|
78-80 |
|
A.N. Fetisova, E.I. Alexeyeva, MD, T.M. Bzarova, N.I. Taybulatov, A.V. Starikova, A.V. Anikin, G.A. Bekdzhanyan
EXPERIENCE OF USE OF ETANERCEPT IN EARLY JUVENILE ANKYLOSING SPONDYLITIS
|
81-87 |
Русский
